GENELABS APPOINTS CHIEF OPERATING OFFICERGenelabs Inc. of Redwood City, Calif., on Wednesday said itnamed Janice W. Wohltmann chief operating officer. She will beresponsible for the operations of the company and themanagement of the biopharmaceutical product developmentprograms. Wohltmann will also focus on the clinicaldevelopment of GLQ223, a compound for treating AIDS.

Wohltmann was previously vice president of pharmaceuticalsat Triton Biosciences Inc.


Receptech Corp. of Seattle appointed H. Stewart Parkercompany president. She succeeds Alan Frazier, who left thecompany in January to pursue other business interests. Parkerremains vice president of corporate development at ImmunexCorp. and president of Immunex's Targeted Genetics unit.

(c) 1997 American Health Consultants. All rights reserved.